An exhaled nitric oxide test is primarily used for the diagnosis and treatment of asthma. Other indications for nitric oxide testing are chronic obstructive pulmonary disease, cystic fibrosis, and pulmonary arterial hypertension. The Nitric oxide test measures the level of nitric oxide gas in the sample of exhaled breath, and the results are indicated by the change in the color of the test strip.
The increasing prevalence of respiratory diseases, availability of wide range of products for the diagnosis, and treatment of asthma, chronic obstructive pulmonary disease, as well as other lung disorders drive the market.
Additionally, increasing research and development activities, technological advancements to identify the causes and risk factors for respiratory diseases, and developing new solutions to minimize patient exposure are other major drivers fuelling the global market growth.
The global market is expected to grow at a CAGR of 5.4% during the forecast period.
The global nitric oxide test market is segmented on the basis of product, indication, and end user.
On the basis of the product, the market is segmented into nitric oxide test strips, nitric oxide monitor, and others.
On the basis of the indication, the market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, pulmonary arterial hypertension, and others.
On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic center, home care settings, and others.